LeMaitre to Participate at Upcoming Investor Conferences in November

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

LeMaitre Vascular (Nasdaq:LMAT) has announced its participation in three major investor conferences this November. David Roberts, President, will present at the UBS Global Healthcare Conference in Rancho Palos Verdes on November 13 at 7:15 AM PT, Stifel's Healthcare Conference in New York City on November 19 at 1:50 PM ET, and the Wolfe Research Healthcare Conference in New York City on November 20 at 2:00 PM ET.

LeMaitre specializes in devices and implants for peripheral vascular disease treatment, serving over 200 million affected patients worldwide. The company focuses on developing and manufacturing vascular devices for surgeons, offering a diverse portfolio of branded products for arteries and veins outside the heart.

11/01/2024 - 04:47 PM

BURLINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.

UBS Global Healthcare Conference

Wednesday, November 13, 2024

Terranea Resort, Rancho Palos Verdes, CA

David Roberts, President, will present at 7:15 AM PT

Stifel's 2024 Healthcare Conference

Tuesday, November 19, 2024

Lotte NY Palace Hotel, New York City

David Roberts, President, will present at 1:50 PM ET

Wolfe Research Healthcare Conference 2024

Wednesday, November 20, 2024

Wolfe Research HQ, New York City

David Roberts, President, will present at 2:00 PM ET

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.

FAQ

When is LeMaitre (LMAT) presenting at the UBS Global Healthcare Conference 2024?

LeMaitre (LMAT) will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024, at 7:15 AM PT at the Terranea Resort in Rancho Palos Verdes, CA.

Which investor conferences is LeMaitre (LMAT) attending in November 2024?

LeMaitre (LMAT) is attending three conferences: UBS Global Healthcare Conference on November 13, Stifel's Healthcare Conference on November 19, and Wolfe Research Healthcare Conference on November 20, 2024.

How many patients are affected by peripheral vascular disease that LeMaitre (LMAT) treats?

According to the press release, peripheral vascular disease, which LeMaitre (LMAT) develops treatments for, affects more than 200 million people worldwide.